Geffen Residence & Renewal Ltd (TLV:GEFR)
77.40
+0.30 (0.39%)
At close: Dec 17, 2025
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 168.83 million as of December 17, 2025. Its market cap has increased by 14.67% in one year.
Market Cap
168.83M
Enterprise Value
227.62M
Revenue
84.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
77.40
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 168.83M, an increase of 475.68%. That is a compound annual growth rate of 28.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 168.83M | 13.49% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | 93.74M | 338.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 110.14B |
| Danel (Adir Yeoshua) | 2.76B |
| Kamada | 1.34B |
| BrainsWay | 1.06B |
| Bait Bakfar | 1.04B |
| SofWave Medical | 986.01M |
| Ilex Medical | 707.42M |
| Novolog (Pharm-Up 1966) | 641.15M |